Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Pediatr Blood Cancer. 2022 Feb 7;69(4):e29511. doi: 10.1002/pbc.29511

TABLE 3:

Current Children’s Oncology Group Rhabdomyosarcoma Risk Stratification

Risk Group Stage Clinical Group Age Fusion Status
Low 1 I, II, III (orbit only) Any FOXO1
2 I, II
Intermediate 1 III (non-orbit) Any FOXO1
1, 2, 3 I, II, III FOXO1 +
2, 3 III FOXO1
3 I, II FOXO1
4 IV <10 years FOXO1
High 4 IV >10 years FOXO1
Any FOXO1 +